Silver Book Fact

U.S. spending on cancer treatment has risen greatly over time, from $13.1 billion in 1980 to $72.1 billion in 2004. 

Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman. An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer. Health Affairs. 2012; 31(4): 667-675

Reference

Title
An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-675

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Direct annual spending for prostate cancer is $3.6 billion.  
  • Patients’ treatment times differed during their last year of life, because of increased hospitalization. Treatment times were longest for gastric, lung and ovarian cancers — 35.4, 32.4, and 31.9 days,…  
  • In the U.S., men have a less than 1 in 2 lifetime risk of developing cancer; the risk is a little more than 1 in 3 for women.  
  • Men have nearly a 1 in 2 chance of developing cancer in their lifetime. For women, the risk is around 1 in 3.  
  • In 2007, an estimated 180,510 people (2,030 men and 178,480 women) will be diagnosed with breast cancer.